275 related articles for article (PubMed ID: 19694470)
1. Design, synthesis, and biological activity of a family of novel ceramide analogues in chemoresistant breast cancer cells.
Antoon JW; Liu J; Gestaut MM; Burow ME; Beckman BS; Foroozesh M
J Med Chem; 2009 Sep; 52(18):5748-52. PubMed ID: 19694470
[TBL] [Abstract][Full Text] [Related]
2. Novel ceramide analogues display selective cytotoxicity in drug-resistant breast tumor cell lines compared to normal breast epithelial cells.
Crawford KW; Bittman R; Chun J; Byun HS; Bowen WD
Cell Mol Biol (Noisy-le-grand); 2003 Nov; 49(7):1017-23. PubMed ID: 14682383
[TBL] [Abstract][Full Text] [Related]
3. Novel ceramide analogs as potential chemotherapeutic agents in breast cancer.
Struckhoff AP; Bittman R; Burow ME; Clejan S; Elliott S; Hammond T; Tang Y; Beckman BS
J Pharmacol Exp Ther; 2004 May; 309(2):523-32. PubMed ID: 14742741
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of a ceramide analog containing a disulfide linkage.
Bittman R; Li Z; Samadder P; Arthur G
Cancer Lett; 2007 Jun; 251(1):53-8. PubMed ID: 17141948
[TBL] [Abstract][Full Text] [Related]
6. Lactoferricin-induced apoptosis in estrogen-nonresponsive MDA-MB-435 breast cancer cells is enhanced by C6 ceramide or tamoxifen.
Furlong SJ; Mader JS; Hoskin DW
Oncol Rep; 2006 May; 15(5):1385-90. PubMed ID: 16596215
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of novel shikonin analogues.
Wang W; Dai M; Zhu C; Zhang J; Lin L; Ding J; Duan W
Bioorg Med Chem Lett; 2009 Feb; 19(3):735-7. PubMed ID: 19111464
[TBL] [Abstract][Full Text] [Related]
8. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and growth inhibitory activity of chiral 5-hydroxy-2-N-acyl-(3E)-sphingenines: ceramides with an unusual sphingoid backbone.
Chun J; Byun HS; Arthur G; Bittman R
J Org Chem; 2003 Jan; 68(2):355-9. PubMed ID: 12530860
[TBL] [Abstract][Full Text] [Related]
10. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL
Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of distamycin analogues - new potential anticancer agents.
Drozdowska D; Rusak M; Miltyk W; Midura-Nowaczek K
Arch Pharm (Weinheim); 2009 Feb; 342(2):87-93. PubMed ID: 19173336
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of a novel ceramide analogue via Tebbe methylenation and evaluation of its antiproliferative activity.
Lu X; Arthur G; Bittman R
Org Lett; 2005 Apr; 7(8):1645-8. PubMed ID: 15816773
[TBL] [Abstract][Full Text] [Related]
13. Amidine analogues of melphalan: synthesis, cytotoxic activity, and DNA binding properties.
Bielawska A; Bielawski K; Anchim T
Arch Pharm (Weinheim); 2007 May; 340(5):251-7. PubMed ID: 17458920
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and preliminary biological evaluation of a novel triazole analogue of ceramide.
Kim S; Cho M; Lee T; Lee S; Min HY; Lee SK
Bioorg Med Chem Lett; 2007 Aug; 17(16):4584-7. PubMed ID: 17561396
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of 7-oxasphingosine and -ceramide analogues and their evaluation in a model for apoptosis.
Rajan R; Wallimann K; Vasella A; Pace D; Genazzani AA; Canonico PL; Condorelli F
Chem Biodivers; 2004 Nov; 1(11):1785-99. PubMed ID: 17191816
[TBL] [Abstract][Full Text] [Related]
16. Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer.
Labbozzetta M; Notarbartolo M; Poma P; Maurici A; Inguglia L; Marchetti P; Rizzi M; Baruchello R; Simoni D; D'Alessandro N
Ann N Y Acad Sci; 2009 Feb; 1155():278-83. PubMed ID: 19250217
[TBL] [Abstract][Full Text] [Related]
17. Ceramide synthesis and metabolism as a target for cancer therapy.
Reynolds CP; Maurer BJ; Kolesnick RN
Cancer Lett; 2004 Apr; 206(2):169-80. PubMed ID: 15013522
[TBL] [Abstract][Full Text] [Related]
18. Ceramide promotes the death of human cervical tumor cells in the absence of biochemical and morphological markers of apoptosis.
López-Marure R; Gutiérrez G; Mendoza C; Ventura JL; Sánchez L; Reyes Maldonado E; Zentella A; Montaño LF
Biochem Biophys Res Commun; 2002 May; 293(3):1028-36. PubMed ID: 12051763
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells.
Minutolo F; Sala G; Bagnacani A; Bertini S; Carboni I; Placanica G; Prota G; Rapposelli S; Sacchi N; Macchia M; Ghidoni R
J Med Chem; 2005 Nov; 48(22):6783-6. PubMed ID: 16250636
[TBL] [Abstract][Full Text] [Related]
20. Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance.
Ogretmen B; Hannun YA
Drug Resist Updat; 2001 Dec; 4(6):368-77. PubMed ID: 12030784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]